Monoclonal Mouse anti‑Human MAP2K2 / MKK2 / MEK2 Antibody (clone 8D10, IF, WB) LS‑C197998
Monoclonal Mouse anti‑Human MAP2K2 / MKK2 / MEK2 Antibody (clone 8D10, IF, WB) LS‑C197998
Antibody:
MAP2K2 / MKK2 / MEK2 Mouse anti-Human Monoclonal (8D10) Antibody
Application:
IF, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
MAP2K2 / MKK2 / MEK2 Mouse anti-Human Monoclonal (8D10) Antibody
Application:
IF, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
MEK2 antibody LS-C197998 is an unconjugated mouse monoclonal antibody to human MEK2 (MAP2K2 / MKK2). Validated for ELISA, IF and WB.
Target
Human MAP2K2 / MKK2 / MEK2
Synonyms
MAP2K2 | ERK activator kinase 2 | MAP kinase kinase 2 | MAPK/ERK kinase 2 | MAPKK 2 | MKK2 | MEK 2 | MEK2 | MAPKK2 | PRKMK2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2b,k
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites by Protein A
Immunogen
MAP2K2 (AAH00471, aa 1-360). A partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Specificity
Human MAP2K2 / MKK2 / MEK2
Applications
- Immunofluorescence (10 µg/ml)
- Western blot
- ELISA
Usage
Sandwich ELISA: Recombinant protein. Western Blot: Transfected lysate, Recombinant protein.
Storage
Store at -20°C or lower. Aliquot to avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About MAP2K2 / MKK2 / MEK2
Featured Products
Source:
E. coli
Tag:
His-T7
Reactivity:
Mouse
Range:
0.312-20 ng/ml
Species:
Human, Monkey, Mouse, Rat, Hamster, Pig
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Reactivity:
Human
Range:
0.312-20 ng/ml
Reactivity:
Pig
Range:
0.781-50 ng/ml
Reactivity:
Mouse
Range:
15.6-1000 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 3/27/2023